Category Archives: J Pharmacokinet Pharmacodyn

Quantification of the endogenous growth hormone and prolactin lowering effects of a somatostatin-dopamine chimera using population PK/PD modeling.

Related Articles
Quantification of the endogenous growth hormone and prolactin lowering effects of a somatostatin-dopamine chimera using population PK/PD modeling.
J Pharmacokinet Pharmacodyn. 2020 Apr 04;:
Authors:… Continue reading

Posted in J Pharmacokinet Pharmacodyn | Tagged | Leave a comment